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Introduction: Mesenchymal stem cells are the focus of cell-based repair strategies, but little is 
understood about the impact of donor variability on their clinical outcome. Due to similarities in 
size, weight, architecture and healing mechanism sheep animal models enable clinical translation 
of cell-based orthopaedic treatments. To date, ovine mesenchymal stem cells (oMSC) have not 
been fully characterized and their differentiation potential is not well understood. This study aims 
to investigate donor variability and chondrogenic potential of oMSCs in vitro for the translation of 
cell-based therapies for osteoarthritis and cartilage defects. Methods: Bone marrow oMSCs were 
isolated from 12 adult English mule ewes (age group 2-4 years) to assess the donor variation. To 
assess the differentiation potential of oMSCs for both adipogenesis and osteogenesis in 2D and 
for chondrogenesis in 3D cell organoids, cells were cultured over 20 days. Donor variation was 
assessed histologically using Oil-o-Red, Alizarin red and Alcian blue staining respectively and 
semi-quantitatively for both adipogenesis and osteogenesis, while chondrogenesis potential, was 
assessed by DMMB assay for GAG production. CD marker expression was studied by flow 
cytometry. MNP labelled STRO-4 positive oMSCs of five donors were seeded in 3D collagen I 
gels, cultured for 20 days and subjected to mechanical stimulation in a magnetic bioreactor 
(MICA) to assess the chondrogenic potential. Simultaneously, native sheep cartilage (6 donors, 
8mm diameter samples, n=4) was harvested from femoral distal condyle. Native and engineered 
cartilage’s tissue matrix composition (GAG, total Collagen, Aggrecan, COL II, DNA, total protein) 
were assessed by histology, and biochemical assays and mechanical testing. Results: Our data 
revealed donor variation in the tri-lineage differentiation and CD marker expression across the all 
donors. No clear correlation between donors was observed among the three lineages. For 
example, a donor that was highly responsive during osteogenic differentiation was not necessarily 
as responsive to chondrogenic or adipogenic differentiation. In addition, mechanical stimulation 
resulted in enhanced chondrogenesis compared with unstimulated controls indicated by 
increased GAG production (23.3-28.6 µg GAG/µg DNA) but fell short of native cartilage (73.2-
119.4 µg GAG /µg DNA). Variations were observed across the donors. Similarly, there is clear 
variation in characterisation of native cartilage between different donors. Conclusion: oMSCs 
appear to share similarities in characteristics across individual donors, but at the same time, 
express differences regarding biological properties that may influence the number, phenotype 
and in vitro biological characteristics. This study investigated the use of 2D and 3D culture to 
assess differentiation capacity between different donors before successfully transmitted to 
preclinical animal studies. Acknowledgements: Al-Mutheffer was supported by Iraqi Ministry of 
Higher Education. Special thanks Dr J McLaren from the University of Nottingham for her 
assistance in collecting sheep bone marrow and cartilage and to Prof El Haj’s group in particular 
Dr Markides. 
 
